M2 Pharma - Therapy Areas

Evinova China and Harbour BioMed form AI partnership to accelerate biologics development

7 November 2025 - Health-tech company Evinova and biopharmaceutical company Harbour BioMed (HKEX:02142) on Friday announced a strategic collaboration to apply artificial intelligence (AI) and digital ...

OncoHost receives Proteomics Innovation of the Year in BioTech Breakthrough Awards

7 November 2025 - OncoHost, a technology company focused on transforming the approach to precision medicine for improved patient outcomes, announced on Thursday that it has received 'Proteomics I...

Johnson & Johnson's DARZALEX FASPRO receives US FDA approval

7 November 2025 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for DARZALEX...

HanchorBio to present HCB301 preclinical data at Society for Immunotherapy of Cancer's 40th Annual Meeting

6 November 2025 - HanchorBio Inc (TPEx:7827), a Taiwan-based global clinical-stage biotechnology company, announced on Wednesday that it will present preclinical data on HCB301, a novel tri-specific i...

Lunai Bioworks publishes breakthrough on second-generation allogeneic dendritic cell therapy in vaccines

5 November 2025 - Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefence company, on Wednesday announced the publication of a landmark study detailing its second-generation allogen...

Cizzle Biotechnology signs Letter of Intent with UK diagnostic provider

5 November 2025 - UK based diagnostics developer of early cancer tests Cizzle Biotechnology Holdings plc (LSE: CIZ) announced on Wednesday that it has signed a Letter of Intent with a leading UK medic...